Last reviewed · How we verify
JOBEVNE (BEVACIZUMAB-NWGD)
JOBEVNE (generic name: BEVACIZUMAB-NWGD) is a Vascular Endothelial Growth Factor Inhibitor [EPC] drug developed by BIOCON BIOLOGICS INC. It is currently FDA-approved.
At a glance
| Generic name | BEVACIZUMAB-NWGD |
|---|---|
| Sponsor | BIOCON BIOLOGICS INC |
| Drug class | Vascular Endothelial Growth Factor Inhibitor [EPC] |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
- Leukopenia
- Diarrhea
- Fatigue
- Neutropenia
- Sensory neuropathy
- Diarrhea
- Nausea
- Hypertension
- Vomiting
- Asthenia
- Dehydration
- Deep vein thrombosis
Serious adverse events
- Hemorrhage
- Intra-abdominal thrombosis
- Syncope
- Ileus
- Deep vein thrombosis
- Dehydration
- Vomiting
- Hypertension
- Sensory neuropathy
- Fatigue
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- JOBEVNE CI brief — competitive landscape report
- JOBEVNE updates RSS · CI watch RSS
- BIOCON BIOLOGICS INC portfolio CI
Frequently asked questions about JOBEVNE
What is JOBEVNE?
JOBEVNE (BEVACIZUMAB-NWGD) is a Vascular Endothelial Growth Factor Inhibitor [EPC] drug developed by BIOCON BIOLOGICS INC.
Who makes JOBEVNE?
JOBEVNE is developed and marketed by BIOCON BIOLOGICS INC (see full BIOCON BIOLOGICS INC pipeline at /company/biocon-biologics-inc).
What is the generic name of JOBEVNE?
BEVACIZUMAB-NWGD is the generic (nonproprietary) name of JOBEVNE.
What drug class is JOBEVNE in?
JOBEVNE belongs to the Vascular Endothelial Growth Factor Inhibitor [EPC] class. See all Vascular Endothelial Growth Factor Inhibitor [EPC] drugs at /class/vascular-endothelial-growth-factor-inhibitor-epc.
What development phase is JOBEVNE in?
JOBEVNE is FDA-approved (marketed).
What are the side effects of JOBEVNE?
Common side effects of JOBEVNE include Leukopenia, Diarrhea, Fatigue, Neutropenia, Sensory neuropathy, Diarrhea. Serious adverse events: Hemorrhage, Intra-abdominal thrombosis, Syncope, Ileus.
Related
- Drug class: All Vascular Endothelial Growth Factor Inhibitor [EPC] drugs
- Manufacturer: BIOCON BIOLOGICS INC — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing